Skip to main content
Erschienen in: The Indian Journal of Pediatrics 10/2013

01.10.2013 | Original Article

Outcome of Neuroblastoma in India

verfasst von: Ketan Prasad Kulkarni, Ram Kumar Marwaha

Erschienen in: Indian Journal of Pediatrics | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To assess the outcome of childhood neuroblastoma in India over the last 2 decades, identify management lacunae and suggest remedial measures.

Methods

A comprehensive search to identify literature addressing outcome of childhood neuroblastoma from India was performed. International Society of Paediatric Oncology and American Society of Clinical Oncology Annual-Meeting abstracts were hand searched to identify unpublished data. Clinico-demographic and outcome data was extracted.

Results

Outcome of approximately 700 patients has been published over the last 2 decades with predominantly small to moderate single center series from 6 cities. Primarily non-myeloablative multiagent chemotherapy protocols alongwith surgery, have been used for treatment. A large majority of patients had stage III/IV neuroblastoma. Limited diagnostic facilities were available at most centers. Survival outcome of 8.7 to 80 % has been reported with high death and relapse rates alongwith high incomplete control/disease progression and treatment abandonment. Few series have identified prognostic parameters. Few patients with high-risk disease have been adequately treated and cured.

Conclusions

There is a clear need for replicating neuroblastoma outcomes at centers of excellence in other cancer centers, improving diagnostic and laboratory facilities, administering adequate and appropriate contemporary therapy, assessing disease response and improving supportive care. National data management infrastructure along with better financial and social support initiatives are key factors.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Pizzo P, Poplack D. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2010. Pizzo P, Poplack D. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2010.
2.
Zurück zum Zitat Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46:264–73.PubMedCrossRef Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46:264–73.PubMedCrossRef
3.
Zurück zum Zitat Bansal D, Marwaha RK, Trehan A, Rao KL, Gupta V. Profile and outcome of neuroblastoma with convertional chemotherapy in children older than 1 y: a 15-y experience. Indian Pediatr. 2008;45:135–9.PubMed Bansal D, Marwaha RK, Trehan A, Rao KL, Gupta V. Profile and outcome of neuroblastoma with convertional chemotherapy in children older than 1 y: a 15-y experience. Indian Pediatr. 2008;45:135–9.PubMed
4.
Zurück zum Zitat Rahi R, Vijyendra K, Sharma SP, et al. A comparative study of intratumoral chemotherapy in advanced childhood common solid tumors. Indian J Urol. 2007;23:358–65.PubMedCrossRef Rahi R, Vijyendra K, Sharma SP, et al. A comparative study of intratumoral chemotherapy in advanced childhood common solid tumors. Indian J Urol. 2007;23:358–65.PubMedCrossRef
5.
Zurück zum Zitat Kusumakumary P, Ajithkumar TV, Ratheesan K, Chellam VG, Nair MK. Pattern and outcome of neuroblastoma. A 10 y study. Indian Pediatr. 1998;35:223–9.PubMed Kusumakumary P, Ajithkumar TV, Ratheesan K, Chellam VG, Nair MK. Pattern and outcome of neuroblastoma. A 10 y study. Indian Pediatr. 1998;35:223–9.PubMed
6.
Zurück zum Zitat Kharya G, Prakash A, Dua V, et al. Clinical profile, management and outcome of neuroblastoma: a developing country experience. Pediatr Blood Cancer. 2011;57:796. abstract. Kharya G, Prakash A, Dua V, et al. Clinical profile, management and outcome of neuroblastoma: a developing country experience. Pediatr Blood Cancer. 2011;57:796. abstract.
7.
Zurück zum Zitat Kurkure P, Dhamankar V, Vora T, et al. Surviving childhood neuroblastoma: at what cost? Pediatr Blood Cancer. 2011;57:830. abstract. Kurkure P, Dhamankar V, Vora T, et al. Surviving childhood neuroblastoma: at what cost? Pediatr Blood Cancer. 2011;57:830. abstract.
8.
Zurück zum Zitat Mandelia A, Agarwala S, Bakshi S, et al. Neuroblastoma: Outcome over a 14 y period from AIIMS NB 96 protocol. Pediatr Blood Cancer. 2011;57:755. abstract. Mandelia A, Agarwala S, Bakshi S, et al. Neuroblastoma: Outcome over a 14 y period from AIIMS NB 96 protocol. Pediatr Blood Cancer. 2011;57:755. abstract.
9.
Zurück zum Zitat Bhatnagar S, Shastri P, Shenoy P, et al. Neuroblastomas at a pediatric cancer center in Mumbai India – Is the treatment optimal? Pediatr Blood Cancer. 2007;49:402. Bhatnagar S, Shastri P, Shenoy P, et al. Neuroblastomas at a pediatric cancer center in Mumbai India – Is the treatment optimal? Pediatr Blood Cancer. 2007;49:402.
10.
Zurück zum Zitat Nandakumar A, Anantha N, Appaji L, et al. Descriptive epidemiology of childhood cancers in Bangalore. India Cancer Causes Control. 1996;7:405–10.CrossRef Nandakumar A, Anantha N, Appaji L, et al. Descriptive epidemiology of childhood cancers in Bangalore. India Cancer Causes Control. 1996;7:405–10.CrossRef
11.
Zurück zum Zitat Swaminathan R, Rama R, Shanta V. Childhood cancers in Chennai, India, 1990–2001: Incidence and survival. Int J Cancer. 2008;122:2607–11. Swaminathan R, Rama R, Shanta V. Childhood cancers in Chennai, India, 1990–2001: Incidence and survival. Int J Cancer. 2008;122:2607–11.
12.
Zurück zum Zitat Kulkarni KP, Arora RS, Marwaha RK. Survival outcome of childhood acute lymphoblastic leukemia in India: A resource-limited perspective of more than 40 y. J Pediatr Hematol Oncol. 2011;33:475–9. Kulkarni KP, Arora RS, Marwaha RK. Survival outcome of childhood acute lymphoblastic leukemia in India: A resource-limited perspective of more than 40 y. J Pediatr Hematol Oncol. 2011;33:475–9.
13.
14.
Zurück zum Zitat Katzenstein HM, Bowman LC, Brodeur GM, et al. Prognostic significance of age, MYCN, oncogene amplification, tumor cell ploidy and histology in 110 infants with stage D(S) neuroblastoma: Pediatric oncology group experience- A Pediatric Oncology Group study. J Clin Oncol. 1998;16:2007–17. Katzenstein HM, Bowman LC, Brodeur GM, et al. Prognostic significance of age, MYCN, oncogene amplification, tumor cell ploidy and histology in 110 infants with stage D(S) neuroblastoma: Pediatric oncology group experience- A Pediatric Oncology Group study. J Clin Oncol. 1998;16:2007–17.
15.
Zurück zum Zitat Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma staging, and response to treatment. J Clin Oncol. 1993;11:1466–77.PubMed Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma staging, and response to treatment. J Clin Oncol. 1993;11:1466–77.PubMed
Metadaten
Titel
Outcome of Neuroblastoma in India
verfasst von
Ketan Prasad Kulkarni
Ram Kumar Marwaha
Publikationsdatum
01.10.2013
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 10/2013
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-012-0948-9

Weitere Artikel der Ausgabe 10/2013

The Indian Journal of Pediatrics 10/2013 Zur Ausgabe

PEDIATRICS IN GENERAL PRACTICE

Urinary Infections in Children

Clinical Brief

Congenital Amastia

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.